HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.

Direct download: 035_-_Empagliflozin_and_dulaglutide.mp3
Category:general -- posted at: 10:03am EST

1